Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-Deoxy-D-Glucose controlled human rhinovirus challenge study in healthy adults
NL-OMON60753Phase 2Completed
- Sponsor
- G.ST Antivirals
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in rhinoviral infection comparing 2-deoxy-D-glucose with Placebo (2 arms). Primary endpoint: Rate of rhinovirus-associated illness. Started Feb 2024; status: completed.
02
Drugs
2-deoxy-d-glucose
03
Conditions
rhinoviral infection
Beyond the preview
Go deeper on NL-OMON60753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60753.